News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Ending disparities starts with understanding the why: International Myeloma Foundation
Mar 25, 2025, 08:26

Ending disparities starts with understanding the why: International Myeloma Foundation

International Myeloma Foundation shared a post on LinkedIn:

“Ending disparities starts with understanding the why. Genetic factors matter! Learn more about how the IMF is committed to ending disparities in multiple myeloma with the IMFMPOWER project.”

More posts featuring International Myeloma Foundation.

cancer IMF International Myeloma Foundation multiple myeloma Myeloma OncoDaily Oncology
Special Coverage
Blog
Mar 25, 2025, 08:26
Angelo Dipasquale: How to manage chemotherapy in a liver transplant recipient diagnosed with an IDH mutant glioma?
Blog
Mar 25, 2025, 08:26
Ending disparities starts with understanding the why: International Myeloma Foundation
Blog
Mar 25, 2025, 08:22
Steven O'Day on the latest innovations and the future of immunotherapy
Blog
Mar 25, 2025, 08:11
The most important lesson from Dr. Matti Aapro - CancerWorld
Blog
Mar 25, 2025, 08:07
Oliver Henke: Kick-starting our new project, FAST-ABCD
Blog
Mar 25, 2025, 07:52
Andreas Charalambous: What is the connection between the TRANSiTION project and Virtual Reality?
Career
Mar 25, 2025, 07:39
Peter Zang: Honored to be this year's recipient of the MOASC Cary Presant YIA award
Blog
Mar 25, 2025, 07:36
Norman Ng: Precise support to reduce the burden of drug costs?
Blog
Mar 25, 2025, 07:21
Zainab Shinkafi-Bagudu: Empowering Women’s Health - Breaking Barriers and Driving Change
Blog
Mar 25, 2025, 07:03
Three more speaker announced for the Young Cancer Professionals Roundtable - ECO
Radiotherapy
Mar 25, 2025, 06:55
What Is Image-Guided Radiation Therapy and How It Works? Pros and Cons
Blog
Mar 25, 2025, 06:52
Aakash Desai: Oncology dealmakers seek multi-indication therapies